14.11.2014 Views

NHMRC Glaucoma Guidelines - ANZGIG

NHMRC Glaucoma Guidelines - ANZGIG

NHMRC Glaucoma Guidelines - ANZGIG

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>NHMRC</strong> GUIDELINES FOR THE SCREENING, PROGNOSIS, DIAGNOSIS, MANAGEMENT AND PREVENTION OF GLAUCOMA<br />

Chapter 10 – Laser therapy and surgery<br />

■ Chapter 10<br />

Laser therapy and surgery<br />

Recommendation 12<br />

Reduce IOP by using laser techniques and incisional surgery.<br />

Good Practice Points<br />

• Offer laser trabeculoplasty as an alternative, or additive to medications.<br />

• Offer surgical IOP reduction when medications and/or laser trabeculoplasty fail to meet targets or are<br />

unsuitable, and visual disability is threatened. There are inherent risks with invasive procedures, which<br />

must be justified by likely benefits.<br />

• <strong>Glaucoma</strong> drainage devices may control IOP long-term and may be suitable if other drainage surgery<br />

fails, or as first-line surgery in eyes with higher risks of failure (including inflammatory glaucomas and<br />

ICE syndrome).<br />

Recommendation 13<br />

If indicated, perform prophylactic laser peripheral iridotomy in both eyes to<br />

prevent progressive anterior segment damage.<br />

Good Practice Point<br />

• Peripheral iridoplasty might be useful after iridotomy in individual cases. Consider cataract extraction<br />

and ongoing IOP control, including trabeculectomy as required.<br />

Recommendation 14<br />

Ensure patients are aware of risks and symptoms of angle-closure and can<br />

access care urgently as necessary.<br />

Introduction<br />

All clinical guidelines highlight the importance of choosing the most appropriate management<br />

approach on a case-by-case basis. Traditionally, glaucoma treatment has begun with medications,<br />

proceeding to laser therapy and surgery when necessary. This approach was designed to maximise<br />

the benefit of treatment while minimising risk to the patient. When making the choice of a<br />

specific form of treatment or the decision to alter or provide additional treatment, the overriding<br />

consideration must be to minimise the risks and maximise the benefit to the patient. All forms of<br />

treatment for glaucoma have potential side effects or complications, and the possible impact of the<br />

treatment, must be evaluated from a social, psychological, financial, and convenience standpoint.<br />

National Health and Medical Research Council 139

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!